JW Pharmaceutical Corp
KRX:001060

Watchlist Manager
JW Pharmaceutical Corp Logo
JW Pharmaceutical Corp
KRX:001060
Watchlist
Price: 25 900 KRW
Market Cap: 617.5B KRW
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Income Statement

Revenue
+
3Y
+16%
5Y
+45%
10Y
+69%
Operating Income
+
3Y
+117%
5Y
-
10Y
+286%
Net Income
+
3Y
+499%
5Y
-
10Y
+998%

Earnings Waterfall
JW Pharmaceutical Corp

Revenue
742.8B KRW
Cost of Revenue
-398.7B KRW
Gross Profit
344.2B KRW
Operating Expenses
-253.8B KRW
Operating Income
90.4B KRW
Other Expenses
-41.5B KRW
Net Income
48.8B KRW

Income Statement
JW Pharmaceutical Corp

Rotate your device to view
Income Statement
Currency: KRW
Dec-2012 Mar-2013 Jun-2013 Sep-2013 Dec-2013 Mar-2014 Jun-2014 Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024 Dec-2024 Mar-2025 Jun-2025
Revenue
Interest Expense
24 392
0
0
10 481
20 653
14 732
19 133
18 464
17 282
16 266
15 798
14 986
14 280
14 345
13 588
13 041
12 115
10 823
10 011
9 151
8 880
8 837
8 958
8 757
8 688
10 979
10 792
10 918
11 279
8 906
9 026
7 705
7 587
6 969
5 916
6 816
7 337
8 150
9 562
10 524
9 387
9 421
10 699
11 402
12 562
12 986
11 448
10 470
10 033
0
0
Revenue
397 085
N/A
386 526
-3%
397 591
+3%
401 971
+1%
394 182
-2%
395 535
+0%
386 067
-2%
386 064
0%
412 791
+7%
426 012
+3%
439 803
+3%
447 788
+2%
434 352
-3%
447 416
+3%
452 149
+1%
460 523
+2%
467 465
+2%
471 517
+1%
476 290
+1%
490 656
+3%
502 919
+2%
510 284
+1%
521 667
+2%
534 920
+3%
537 182
+0%
536 809
0%
538 270
+0%
524 767
-3%
511 335
-3%
510 079
0%
512 402
+0%
516 529
+1%
547 336
+6%
560 407
+2%
569 978
+2%
581 827
+2%
606 585
+4%
620 832
+2%
639 806
+3%
660 661
+3%
684 351
+4%
701 393
+2%
895 695
+28%
910 051
+2%
748 527
-18%
929 120
+24%
742 090
-20%
736 543
-1%
719 376
-2%
724 018
+1%
742 847
+3%
Gross Profit
Cost of Revenue
(268 107)
(260 365)
(259 320)
(262 588)
(249 699)
(248 007)
(247 800)
(242 821)
(261 518)
(273 619)
(278 296)
(284 806)
(273 729)
(282 184)
(283 866)
(289 650)
(294 121)
(294 200)
(296 504)
(307 709)
(314 286)
(318 378)
(325 530)
(322 058)
(340 142)
(343 676)
(347 316)
(352 714)
(350 216)
(350 751)
(361 290)
(368 302)
(369 810)
(367 206)
(360 118)
(359 582)
(372 209)
(381 077)
(390 548)
(395 943)
(396 397)
(401 974)
(502 110)
(504 189)
(412 984)
(510 549)
(411 745)
(401 807)
(395 878)
(399 371)
(398 659)
Gross Profit
128 978
N/A
126 160
-2%
138 270
+10%
139 383
+1%
144 484
+4%
147 529
+2%
138 268
-6%
143 242
+4%
151 274
+6%
152 391
+1%
161 505
+6%
162 981
+1%
160 623
-1%
165 232
+3%
168 283
+2%
170 873
+2%
173 344
+1%
177 317
+2%
179 786
+1%
182 947
+2%
188 632
+3%
191 905
+2%
196 136
+2%
212 861
+9%
197 040
-7%
193 133
-2%
190 954
-1%
172 053
-10%
161 119
-6%
159 329
-1%
151 113
-5%
148 228
-2%
177 526
+20%
193 202
+9%
209 860
+9%
222 247
+6%
234 376
+5%
239 754
+2%
249 258
+4%
264 719
+6%
287 955
+9%
299 419
+4%
393 585
+31%
405 862
+3%
335 542
-17%
418 571
+25%
330 346
-21%
334 735
+1%
323 498
-3%
324 647
+0%
344 188
+6%
Operating Income
Operating Expenses
(119 492)
(117 726)
(117 363)
(115 903)
(118 583)
(119 538)
(121 168)
(127 740)
(133 163)
(136 281)
(138 129)
(139 935)
(138 875)
(141 679)
(144 862)
(148 406)
(148 806)
(152 490)
(156 566)
(158 690)
(166 914)
(172 602)
(176 046)
(176 733)
(175 456)
(176 054)
(175 775)
(175 989)
(180 133)
(182 430)
(180 994)
(180 631)
(178 849)
(185 463)
(194 743)
(199 685)
(203 176)
(205 499)
(207 604)
(219 078)
(224 994)
(229 457)
(292 483)
(297 742)
(235 239)
(292 377)
(232 677)
(236 634)
(241 010)
(247 625)
(253 836)
Selling, General & Administrative
(103 473)
(100 110)
(110 275)
(109 641)
(105 119)
(107 616)
(104 757)
(109 760)
(115 682)
(118 891)
(121 148)
(123 133)
(122 394)
(124 278)
(127 568)
(130 779)
(130 801)
(133 904)
(135 734)
(137 106)
(144 933)
(150 694)
(155 566)
(156 260)
(154 188)
(152 384)
(150 039)
(149 822)
(149 110)
(151 793)
(152 025)
(152 487)
(155 905)
(162 052)
(172 305)
(176 448)
(183 293)
(183 109)
(184 280)
(192 264)
(191 257)
(194 986)
(248 039)
(246 377)
(201 567)
(251 347)
(198 551)
(202 197)
(204 773)
(207 077)
(209 965)
Research & Development
(12 357)
0
0
(5 631)
(13 464)
(11 233)
(15 722)
(16 720)
(17 482)
(17 390)
(16 706)
(16 804)
(16 480)
(17 318)
(17 209)
(17 624)
(18 005)
(18 585)
(20 832)
(21 134)
(21 982)
(21 457)
(20 479)
(20 473)
(21 268)
(21 479)
(24 211)
(24 774)
(25 220)
(24 833)
(23 165)
(22 341)
(22 943)
(22 654)
(21 681)
(22 479)
(19 884)
(21 490)
(22 424)
(25 914)
(33 736)
(34 471)
(44 087)
(43 475)
(33 671)
(40 673)
(34 503)
(34 814)
(36 237)
(39 322)
(42 646)
Depreciation & Amortization
(3 662)
0
0
(631)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(5 804)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Operating Expenses
0
(17 616)
(7 088)
0
0
(689)
(689)
(1 260)
0
0
(275)
0
0
(83)
(85)
(3)
0
0
0
(450)
0
(451)
0
0
0
(2 191)
(1 525)
(1 393)
0
(5 804)
(5 804)
(5 803)
0
(757)
(758)
(758)
0
(900)
(900)
(900)
0
0
(357)
(7 890)
0
(357)
377
377
0
(1 226)
(1 226)
Operating Income
9 486
N/A
8 434
-11%
20 907
+148%
23 480
+12%
25 900
+10%
27 991
+8%
17 100
-39%
15 503
-9%
18 110
+17%
16 111
-11%
23 377
+45%
23 047
-1%
21 749
-6%
23 554
+8%
23 422
-1%
22 467
-4%
24 538
+9%
24 827
+1%
23 220
-6%
24 257
+4%
21 718
-10%
19 304
-11%
20 091
+4%
36 129
+80%
21 584
-40%
17 079
-21%
15 179
-11%
(3 936)
N/A
(19 014)
-383%
(23 101)
-21%
(29 881)
-29%
(32 403)
-8%
(1 323)
+96%
7 737
N/A
15 115
+95%
22 560
+49%
31 200
+38%
34 256
+10%
41 654
+22%
45 641
+10%
62 961
+38%
69 962
+11%
101 102
+45%
108 120
+7%
100 304
-7%
126 194
+26%
97 669
-23%
98 101
+0%
82 488
-16%
77 022
-7%
90 352
+17%
Pre-Tax Income
Interest Income Expense
(22 074)
(20 504)
(21 049)
(19 689)
(16 253)
(18 366)
(15 141)
(14 666)
(9 421)
(9 179)
(8 808)
(9 145)
(13 988)
(15 329)
(15 577)
(14 875)
(14 350)
(13 772)
(11 572)
(10 603)
(13 044)
(10 339)
(10 269)
(11 600)
(7 760)
(7 693)
(7 316)
(5 037)
(11 341)
(9 876)
(10 195)
(10 378)
(10 332)
(9 690)
(10 264)
(9 204)
(8 356)
(8 321)
(8 336)
(7 482)
(2 748)
(761)
(1 543)
(3 182)
(3 979)
(4 766)
(2 828)
(2 155)
(2 365)
(1 936)
(404)
Non-Reccuring Items
0
0
0
0
(1 025)
(1 259)
(1 259)
0
(1 406)
(276)
0
(359)
(197)
0
0
(160)
(160)
(160)
(610)
0
(450)
0
(665)
(798)
(2 191)
0
0
0
817
0
0
0
(760)
0
0
0
(900)
0
0
0
(7 533)
(7 890)
(7 533)
0
0
734
0
0
(849)
0
0
Gain/Loss on Disposition of Assets
(2 575)
0
0
(2 637)
(5 865)
(4 545)
(5 929)
(5 658)
(5 354)
(4 974)
(5 344)
(4 446)
(4 339)
(4 433)
(3 943)
(4 388)
(4 458)
(4 417)
(4 229)
(4 214)
(3 952)
(3 692)
(3 927)
(4 038)
(4 104)
(7 032)
(6 411)
(5 989)
(2 926)
(2 620)
(2 447)
(2 304)
(1 971)
(2 790)
(2 323)
(1 708)
(1 048)
72
125
43
3
2
(1 064)
(1 088)
(1 088)
(1 091)
(24)
(22)
465
463
0
Total Other Income
11
(2 603)
(1 765)
(5)
649
975
1 189
780
(68)
(741)
(1 502)
(897)
(944)
(1 082)
(2 140)
(8 209)
1 511
(401)
(711)
10 049
(5 620)
(1 774)
8 336
(7 017)
2 705
(1 355)
(9 346)
1 548
(1 871)
2 317
2 100
1 803
1 181
(248)
(451)
(986)
(364)
(168)
(399)
(657)
(7 321)
(5 855)
(2 860)
(37 147)
(40 401)
(39 796)
(42 123)
(6 729)
2 681
3 292
(1 237)
Pre-Tax Income
(15 152)
N/A
(14 673)
+3%
(1 907)
+87%
1 149
N/A
3 406
+196%
4 794
+41%
(4 042)
N/A
(4 043)
0%
1 861
N/A
941
-49%
7 724
+721%
8 202
+6%
2 281
-72%
2 711
+19%
1 762
-35%
(5 165)
N/A
7 081
N/A
6 076
-14%
6 097
+0%
19 489
+220%
(1 348)
N/A
3 499
N/A
13 565
+288%
12 674
-7%
10 234
-19%
998
-90%
(7 895)
N/A
(13 415)
-70%
(34 335)
-156%
(33 281)
+3%
(40 423)
-21%
(43 282)
-7%
(13 205)
+69%
(4 990)
+62%
2 077
N/A
10 662
+413%
20 533
+93%
25 839
+26%
33 044
+28%
37 545
+14%
45 362
+21%
55 459
+22%
88 101
+59%
66 703
-24%
54 836
-18%
81 274
+48%
52 695
-35%
89 195
+69%
82 420
-8%
78 842
-4%
88 711
+13%
Net Income
Tax Provision
(5 242)
(4 890)
(7 218)
(7 723)
(1 131)
(1 698)
1 394
1 392
(414)
(515)
(2 856)
(2 823)
(145)
365
(14 538)
(13 457)
(18 015)
(17 549)
(2 402)
(5 267)
606
(512)
(1 001)
(3 563)
(2 177)
(2 230)
(374)
3 984
9 060
9 938
7 101
11 773
(2 070)
(3 468)
(5 824)
(12 341)
(21 974)
(21 911)
(24 473)
(25 858)
(15 509)
(19 646)
(21 763)
(26 416)
(16 406)
(22 757)
(17 042)
(15 785)
(17 379)
(16 419)
(36 664)
Income from Continuing Operations
(20 394)
(19 562)
(9 125)
(6 575)
2 275
3 095
(2 648)
(2 651)
1 447
426
4 868
5 379
2 136
3 076
(12 776)
(18 621)
(10 934)
(11 471)
3 698
14 224
(742)
2 989
12 566
9 113
8 057
(1 231)
(8 269)
(9 431)
(25 275)
(23 342)
(33 321)
(31 508)
(15 275)
(8 458)
(3 746)
(1 679)
(1 441)
3 928
8 571
11 687
29 853
35 812
66 337
40 287
38 430
58 518
35 653
73 410
65 040
62 423
52 047
Income to Minority Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
1
5
34
(11)
418
480
474
656
359
443
2 039
2 021
466
316
(1 424)
(1 424)
0
0
0
0
0
Net Income (Common)
(20 422)
N/A
(19 587)
+4%
(9 151)
+53%
(6 593)
+28%
2 245
N/A
2 870
+28%
(3 064)
N/A
(3 272)
-7%
617
N/A
(195)
N/A
4 447
N/A
5 159
+16%
2 117
-59%
3 056
+44%
(12 795)
N/A
(18 636)
-46%
(11 636)
+38%
(12 344)
-6%
2 650
N/A
12 560
+374%
(2 058)
N/A
1 309
N/A
10 231
+682%
7 052
-31%
6 795
-4%
(1 957)
N/A
(8 163)
-317%
(8 981)
-10%
(24 785)
-176%
(22 708)
+8%
(32 241)
-42%
(30 582)
+5%
(14 381)
+53%
(7 989)
+44%
(3 099)
+61%
(1 110)
+64%
(916)
+17%
4 263
N/A
8 157
+91%
11 035
+35%
30 312
+175%
35 760
+18%
63 415
+77%
38 775
-39%
35 096
-9%
53 869
+53%
33 440
-38%
68 958
+106%
60 781
-12%
58 569
-4%
48 848
-17%
EPS (Diluted)
-1 361.46
N/A
-1 224.18
+10%
-538.29
+56%
-387.82
+28%
132.05
N/A
151.05
+14%
-170.22
N/A
-181.77
-7%
34.27
N/A
-9.75
N/A
211.76
N/A
245.66
+16%
100.8
-59%
145.52
+44%
-609.28
N/A
-887.42
-46%
-554.09
+38%
-587.8
-6%
126.19
N/A
598.09
+374%
-98
N/A
62.33
N/A
487.19
+682%
335.8
-31%
323.57
-4%
-93.19
N/A
-371.04
-298%
-427.66
-15%
-1 180.23
-176%
-1 081.33
+8%
-1 535.28
-42%
-1 456.28
+5%
-684.8
+53%
-380.42
+44%
-140.28
+63%
-50.24
+64%
-38.33
+24%
193.07
N/A
358.68
+86%
485.26
+35%
1 267.1
+161%
1 531.79
+21%
2 718.38
+77%
1 662.56
-39%
1 503.91
-10%
2 309.46
+54%
1 433.67
-38%
2 956.47
+106%
2 605.86
-12%
2 539.62
-3%
2 122.44
-16%

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 307,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.